A therapeutic antibody targeting osteoprotegerin attenuates severe experimental pulmonary arterial hypertension. (2019)
Attributed to:
Investigation of MiR-140-5p in Humans and Experimental Models of Pulmonary Arterial Hypertension.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.17863/cam.48128
Publication URI: https://www.repository.cam.ac.uk/handle/1810/301051
Type: Journal Article/Review